Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2010||Chairman of the Supervisory Board|
|Chairman of the Management Board, Chief Executive Officer|
|56||2012||Deputy Chairman of the Supervisory Board|
|2014||Chief Financial Officer, Member of the Management Board|
|2018||Member of the Management Board, Chief Development Officer|
- BRIEF-PAION Grants Exclusive License To Mundipharma For Development And Commercialization Of Remimazolam In Japan
- BRIEF-PAION announces clinical development progress with remimazolam
- BRIEF-PAION: FDA considers current human abuse liability program with remimazolam in U.S. as sufficient
- BRIEF-PAION 9-mth net loss at 8.5 mln euros
- BRIEF-Paion: Japan patent office grants dosing patent for remimazolam